| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/02/2010 | CN101122590B Limestone activity test method and test device for wet process of FGD |
| 06/02/2010 | CN101044386B Tire wear analysis method |
| 06/02/2010 | CN101018856B Selective culture method and isolation method of small hepatocytes with hialuronic acid |
| 06/01/2010 | US7729868 Method for analyzing structure of glycoprotein |
| 06/01/2010 | US7729867 Method for introducing conjugated caps onto molecular fragments and systems and methods for using the same to determine inter-molecular interaction energies |
| 06/01/2010 | US7729866 Method of determining level of specified component in blood sample and apparatus for level determination |
| 06/01/2010 | US7729865 Computerized method and system for automated correlation of genetic test results |
| 06/01/2010 | US7729517 Method and apparatus for testing fibres |
| 06/01/2010 | US7728982 Fiber-optic assay apparatus based on phase-shift interferometry |
| 06/01/2010 | US7728606 Measurement instrument |
| 06/01/2010 | US7728189 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression |
| 06/01/2010 | US7728153 anticancer agents; angiogenesis inhibitors; fatty acid synthase inhibitors |
| 06/01/2010 | US7728127 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/01/2010 | US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection |
| 06/01/2010 | US7728115 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 06/01/2010 | US7728112 Kit comprising epitope specific immunoglobulin for use in diagnosis/prognosis of bone disorders; Antiarthritic agents; screenning for osteoarthritis |
| 06/01/2010 | US7728111 Anti-p55 TNF receptor antibody |
| 06/01/2010 | US7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
| 06/01/2010 | US7727957 Treatment and delay of outset of Parkinson's disease |
| 06/01/2010 | US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs |
| 06/01/2010 | US7727950 Methods and reagents for assaying protein kinase activity |
| 06/01/2010 | US7727776 Core-shell nanoparticles for detection based on SERS |
| 06/01/2010 | US7727775 Optical microlabels: shapes and reflectors |
| 06/01/2010 | US7727768 Method for a nanocalorimeter for detecting chemical reactions |
| 06/01/2010 | US7727767 Using decomposing resin materials as tool in detecting hazardous substances and lead |
| 06/01/2010 | US7727766 Method and apparatus for testing heavy oil production processes |
| 06/01/2010 | US7727760 Tissue propagation basin; tissue targeted therapy |
| 06/01/2010 | US7727757 For invoking an immune response, delaying the onset of AIDS in an animal exposed to infectious HIV |
| 06/01/2010 | US7727739 Methods for measuring enzyme activity |
| 06/01/2010 | US7727736 Monitoring Factor Xa or thrombin enzyme activities using enhanced phosphatidylserine (PS), phosphatidylhomoserine, phosphatidylethanolamine and/or phosphatidic acid; improved shelf-life, reproducibility and ease of manufacture |
| 06/01/2010 | US7727735 Detection and treatment of prostate cancer |
| 06/01/2010 | US7727734 Screening for presence/absence of host hemoglobin/parasite salivary protein mix in environmental dust; evaluating bedbug feeding behavior; verifying insect infestation |
| 06/01/2010 | US7727733 Diagnosis of preeclampsia |
| 06/01/2010 | US7727732 Identifying regulatory agents for treatment and prevention of hyperproliferative or hypoproliferative disorders |
| 06/01/2010 | US7727731 Potent, selective and non toxic c-kit inhibitors |
| 06/01/2010 | US7727730 Methods and kits for detection of thromboxane A2 metabolites |
| 06/01/2010 | US7727729 Using taste specific g protein coupled receptors as tools in identifying modulator which can be used to customize taste in food and pharmaceuticals |
| 06/01/2010 | US7727728 Method for the in vitro titration of an NCTA application thereof in a method for the evaluation and/or monitoring of a biological product production method |
| 06/01/2010 | US7727718 Reagents for storage and preparation of samples for DNA analysis |
| 06/01/2010 | US7727711 Using type IV secretion (T4S) substrate (BepA) specific immunoglobulin to diagnose proteobacterium infection |
| 06/01/2010 | US7727710 Materials, methods, and kits for reducing nonspecific binding of molecules to a surface |
| 06/01/2010 | US7727567 Method of establishing the integrity of a product located in a container |
| 06/01/2010 | US7727536 EG-VEGF nucleic acids and polypeptides and methods of use |
| 06/01/2010 | US7727534 Gentically engineered viral particles for use in targeted tumor destruction; Antitumor agents |
| 06/01/2010 | US7727529 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection |
| 06/01/2010 | US7727528 Tumor necrosis factor receptor 1 specific immunoglobulins for targeted immaging and treatment and diagnosis of cell proliferative and autoimmune disorders |
| 06/01/2010 | US7727472 Chemical analysis apparatus and chemical analysis cartridge |
| 06/01/2010 | US7727468 test kit having a visual pH indicator changing color at a pH above 4.0; measuring and quantifying the capacity of moisture; containing lotions and to quantify the ability to neutralize alkalinity the residues of feces and urine over time on the baby skin, restore to a natural pH; wiping articles |
| 06/01/2010 | US7727467 Reagent stripe for test strip |
| 06/01/2010 | US7727466 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer |
| 06/01/2010 | US7727286 Stretch fabrics with improved chemical resistance |
| 06/01/2010 | US7727206 Device for monitoring a patient for a urinary tract infection |
| 06/01/2010 | US7726214 Method and device for the contactless detection of flat objects |
| 06/01/2010 | US7726203 Multiphase Coriolis flowmeter |
| 06/01/2010 | CA2569217C Methods for adjusting stress wave velocity-based predictions of lumber stiffness and warp propensity of a timber-based raw material group |
| 06/01/2010 | CA2537147C System and process for monitoring the production of synthetic fuel |
| 06/01/2010 | CA2519449C Method for screening transglutaminase 2 inhibitor or activator |
| 06/01/2010 | CA2466503C Total cysteine assay |
| 06/01/2010 | CA2441952C Plasmodium falciparum ama-1 protein and uses thereof |
| 06/01/2010 | CA2424171C Flexible protocol generator |
| 06/01/2010 | CA2384186C System and method for programmable illumination pattern generation |
| 06/01/2010 | CA2380382C A method of determining parameters of formations through which a borehole passes |
| 06/01/2010 | CA2378742C Preparation of spheres for diagnostic tests |
| 06/01/2010 | CA2370666C A tenascin-c isoform as a marker for neoplasias |
| 06/01/2010 | CA2369045C Methods for improving sensitivity and specificity of screening assays |
| 06/01/2010 | CA2336221C Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 06/01/2010 | CA2288373C Human cerberus protein |
| 06/01/2010 | CA2250286C Fluorescent-tagged polymers for boiler internal treatment |
| 06/01/2010 | CA2230546C Method for evaluating reaction profiles |
| 06/01/2010 | CA2221495C Methods and uses for apoptin |
| 06/01/2010 | CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 06/01/2010 | CA2115839C Hla-restricted hepatitis b virus ctl epitopes |
| 05/28/2010 | CA2645452A1 Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker |
| 05/27/2010 | WO2010060102A2 Prediction and prevention of preeclampsia |
| 05/27/2010 | WO2010060081A1 Method of determining pegylated blood coagulation factor activity in a silica-based activated partial thromboplastin time assay |
| 05/27/2010 | WO2010060055A1 Predicting cancer risk and treatment success |
| 05/27/2010 | WO2010060046A2 Dye probe fluorescence resonance energy transfer genotyping |
| 05/27/2010 | WO2010060032A1 Method for determining progression of ductal carcinoma in situ to invasive breast cancer |
| 05/27/2010 | WO2010060019A2 Methods for characterizing molecules |
| 05/27/2010 | WO2010059985A2 Redox-activated patterning |
| 05/27/2010 | WO2010059971A1 Diagnosing and monitoring response to treatment of non-incontinent urological and related diseases |
| 05/27/2010 | WO2010059958A2 Artificial lectin mimics and uses thereof |
| 05/27/2010 | WO2010059952A1 Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers |
| 05/27/2010 | WO2010059880A2 Photo-induced damage mitigating agents and preparation and methods of use thereof |
| 05/27/2010 | WO2010059820A1 Biosensor for detecting multiple epitopes on a target |
| 05/27/2010 | WO2010059785A1 Cloning, expression and purication of recombinant porcine intrinsic factor for use in diagnostic assay |
| 05/27/2010 | WO2010059709A2 Metabolic syndrome and hpa axis biomarkers for major depressive disorder |
| 05/27/2010 | WO2010059687A2 A semiconductor for measuring biological interactions |
| 05/27/2010 | WO2010059686A2 Markers for preeclampsia |
| 05/27/2010 | WO2010059661A1 Methods of determining polydispersity and/or molecular weight distribution of a polyethylene glycol sample |
| 05/27/2010 | WO2010059643A2 Direct vessel heating for dissolution testing |
| 05/27/2010 | WO2010059635A1 Apparatus for sanitizing writing utensils |
| 05/27/2010 | WO2010059569A2 Analyzers and methods related thereto |
| 05/27/2010 | WO2010059543A1 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
| 05/27/2010 | WO2010059541A1 Platelet-derived pf4 as efficacy marker for anti-angiogenic therapies |
| 05/27/2010 | WO2010059487A1 Biosensor article, cell culture article and methods thereof |
| 05/27/2010 | WO2010059400A1 Methods and kits to identify invasive glioblastoma |
| 05/27/2010 | WO2010059351A2 Substrate for manufacturing disposable microfluidic devices |
| 05/27/2010 | WO2010059242A2 Neurodegenerative disease diagnostic compositions and methods of use |
| 05/27/2010 | WO2010059006A2 MEMS CHIP FOR CHROMATIN IMMUNOPRECIPITATION (ChIP) AND CHIP METHOD USING SAME |